Command Palette

Search for a command to run...

ganga-pharmaceuticals

14.6+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Deep Value Pick

Ganga Pharmaceuticals Ltd. is currently underperforming compared to its peers in terms of growth and profitability, with no revenue or earnings recorded. However, it has a low debt-to-equity ratio, positioning it as a potential deep value pick amid a sector with several strong performers like Sun Pharmaceutical Industries and Cipla, which exhibit robust growth and profitability metrics.

Key Points
  • Ganga Pharmaceuticals shows no growth or profitability metrics, making it a passive player in the sector.
  • Sun Pharmaceuticals and Cipla stand out as sector leaders with strong earnings and growth rates.
  • Target company has a very low debt level, making it less financially risky compared to peers.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest revenue growth YoY at 8.42% and strong profitability with an ROE of 16.13%.

Cipla Ltd.

Robust growth with 13.28% revenue growth YoY and very attractive PE ratio of 23.73.

Mankind Pharma Ltd.

Strong growth trajectory with 18.12% revenue growth YoY and solid profitability metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.